Pathologic Bone Resorption and New Bone Formation in Inflammatory Arthritis

• 1. Ogdie A
  2. Merola JF
  3. Mease PJ
  4. Ritchlin CT
  5. Scher JU
  6. Lafferty KP
  7. Chan D
  8. Chakravarty SD
  9. Langholff W
  10. Wang Y
  11. Shao J
  12. Krol Y
  13. Gottlieb AB
  Efficacy and Safety of Guselkumab in Participants with Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of the Phase 3, Randomized, Placebo-Controlled SOLSTICE Study.; Arthritis & rheumatology (Hoboken, N.J.). 2026 Feb 11.
• 1. Kenney HM
  2. Lichau D
  3. Blanc R
  4. Schnur L
  5. Bell RD
  6. Ritchlin CT
  7. Schwarz EM
  8. Awad HA
  9. Wood RW
  Automated Joint Space Detection Improves Bone Segmentation Accuracy.; Journal of visualized experiments : JoVE. 2025 Nov 28.
• 1. Peng Y
  2. Kenney HM
  3. Lydon S
  4. de Mesy Bentley KL
  5. Xing L
  6. Korman BD
  7. Ritchlin CT
  8. Schwarz EM
  The Function of Efhd1+ Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis.; bioRxiv : the preprint server for biology. 2025 Nov 05.
• 1. McInnes IB
  2. Coates LC
  3. Mease PJ
  4. Ogdie A
  5. Kavanaugh A
  6. Eder L
  7. Schett G
  8. Kivitz A
  9. McGonagle D
  10. Brennan N
  11. Godwood A
  12. Cullen E
  13. Reich K
  14. Ritchlin CT
  15. Merola JF
  Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial.; Nature medicine. 2025 Oct 06.

February 6, 2026
Dr. Katherine Herman Presents Medical Grand Rounds

January 23, 2026
Dr. Theresa Bingemann Presents at the AAAAI Program Directors Assembly Winter Meeting

November 21, 2025
Dr. Rangel-Moreno an International Speaker at the Research Seminars in Biological Sciences and International Biomedicine Workshop

October 22, 2025
Dr. Jennifer Anolik Presents at Upstate Medical Center Symposium

October 20, 2025
National Scleroderma Foundation Rochester Education Forum Held at URMC

All News »